Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ZEVRA THERAPEUTICS, INC. (ZVRA)

$9.81 -5.03% NASDAQ: ZVRA · 15-min delayed
  • BOSTON, Massachusetts
  • Public · NASDAQ: ZVRA
  • 61 employees
$563.1MMarket cap
$0Revenue · FY2015
$83.2MNet income
61Employees
ZVRANASDAQ
2015IPO

About ZEVRA THERAPEUTICS, INC.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2015
$0
Net income
$83.2M
Total assets
$284.7M
Market cap
$563.1M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ZVRA
$9.81 -5.03%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$7.95 $14.75

52-week range

Market cap
$563.1M
Shares outstanding
57.4M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Apr 16, 2015

Zevra Therapeutics, Inc. (ZVRA) Stock Price

  • Profitable — net income of $83.2M in FY2015.
  • Trading 33% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ZEVRA THERAPEUTICS, INC..

Write a review
Newsroom

News about ZEVRA THERAPEUTICS, INC.

News & sentiment via Polygon.io

FAQ

Zevra Therapeutics, Inc.: frequently asked questions

Is Zevra Therapeutics, Inc. an American company?

Zevra Therapeutics, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Zevra Therapeutics, Inc. headquartered?

Zevra Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

Is Zevra Therapeutics, Inc. publicly traded?

Yes — Zevra Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ZVRA on the NASDAQ.

What does Zevra Therapeutics, Inc. do?

Zevra Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →